Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Cousens

Showing results (171-180 of 205) with videos related to

Pageof 21
Sort By:
Plos Medicine|February 10, 2011
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trialAmadou T Konaté, Jean Baptiste Yaro, Amidou Z Ouédraogo, et al.
Pediatric Research|December 25, 2013
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levelsVinod K Bhutani, Alvin Zipursky, Hannah Blencowe, et al.
The Lancet. Global Health|May 18, 2019
National, regional, and state-level all-cause and cause-specific under-5 mortality in India in 2000-15: a systematic analysis with implications for the Sustainable Development GoalsLi Liu, Yue Chu, Shefali Oza, et al.
Frontiers in Immunology|September 19, 2022
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe childrenEdith Christiane Bougouma, Nirianne Marie Q Palacpac, Alfred B Tiono, et al.
Plos One|October 27, 2009
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe childrenSodiomon B Sirima, Alfred B Tiono, Alphonse Ouédraogo, et al.
Plos One|August 23, 2011
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trialAmadou T Konaté, Jean Baptiste Yaro, Amidou Z Ouédraogo, et al.
Population Health Metrics|February 9, 2021
Gestational age data completeness, quality and validity in population-based surveys: EN-INDEPTH studyM Moinuddin Haider, Kaiser Mahmud, Hannah Blencowe, et al.
Lancet (London, England)|August 29, 2021
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessmentLucia Hug, Danzhen You, Hannah Blencowe, et al.
BMJ Open|March 20, 2026
Biological impacts of rising temperatures on maternal, fetal and newborn health: protocol for a cohort study (BIRTH-Cohort)Jai K Das, Asma Abdul Malik, Aris T Papageorghiou, et al.
Frontiers in Immunology|November 1, 2023
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trialAlphonse Ouédraogo, Edith Christiane Bougouma, Nirianne Marie Q Palacpac, et al.
Pageof 21

Showing results (171-180 of 205) with videos related to

Sort By:
Pageof 21
Plos Medicine|February 10, 2011
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trialAmadou T Konaté, Jean Baptiste Yaro, Amidou Z Ouédraogo, et al.
Pediatric Research|December 25, 2013
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levelsVinod K Bhutani, Alvin Zipursky, Hannah Blencowe, et al.
The Lancet. Global Health|May 18, 2019
National, regional, and state-level all-cause and cause-specific under-5 mortality in India in 2000-15: a systematic analysis with implications for the Sustainable Development GoalsLi Liu, Yue Chu, Shefali Oza, et al.
Frontiers in Immunology|September 19, 2022
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe childrenEdith Christiane Bougouma, Nirianne Marie Q Palacpac, Alfred B Tiono, et al.
Plos One|October 27, 2009
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe childrenSodiomon B Sirima, Alfred B Tiono, Alphonse Ouédraogo, et al.
Plos One|August 23, 2011
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trialAmadou T Konaté, Jean Baptiste Yaro, Amidou Z Ouédraogo, et al.
Population Health Metrics|February 9, 2021
Gestational age data completeness, quality and validity in population-based surveys: EN-INDEPTH studyM Moinuddin Haider, Kaiser Mahmud, Hannah Blencowe, et al.
Lancet (London, England)|August 29, 2021
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessmentLucia Hug, Danzhen You, Hannah Blencowe, et al.
BMJ Open|March 20, 2026
Biological impacts of rising temperatures on maternal, fetal and newborn health: protocol for a cohort study (BIRTH-Cohort)Jai K Das, Asma Abdul Malik, Aris T Papageorghiou, et al.
Frontiers in Immunology|November 1, 2023
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trialAlphonse Ouédraogo, Edith Christiane Bougouma, Nirianne Marie Q Palacpac, et al.
Pageof 21